FDA clears a Roche and Eli Lilly blood test detecting Alzheimer’s markers in patients 55 and older, replacing costly PET scans and spinal taps.
Runs on 4,500 installed analyzers nationwide
Read the full story at Reuters
From the August 24, 2026 GovBrief, every story that day in one place.